Journal of Antimicrobial Chemotherapy (2003) 51, iii13-iii21
© 2003 The British Society for Antimicrobial Chemotherapy
Supplement |
Clinical impact of vancomycin-resistant enterococci
Division of Infectious Diseases, Department of Internal Medicine, Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Infectious Diseases Research Laboratory, Mayo Clinic and Foundation, 200 First St. S. W., Rochester, MN 55905, USA
Abstract
In humans, vancomycin-resistant enterococci (VRE) most commonly result in intestinal colonization, which does not result in symptoms, may persist for a long time and serves as a reservoir for transmission of VRE to other patients. Certain VRE-colonized patients are at risk of infection, including haematology and oncology patients, patients in intensive care units and recipients of solid (especially abdominal) organ transplants. Controlling the spread of VRE colonization and preventing colonized patients from becoming infected are important aims. Ramoplanin is a member of a new class of antimicrobial agents; it may have a role in preventing infection in patients colonized with VRE.
Keywords: enterococci, glycopeptide resistance, vancomycin
Footnotes
* Tel: +1-507-255-6482; Fax: +1-507-255-7767; E-mail: patel.robin{at}mayo.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. P. MacGowan and on behalf of the BSAC Working Parties on Resistanc Clinical implications of antimicrobial resistance for therapy J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii105 - ii114. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vankerckhoven, G. Huys, M. Vancanneyt, C. Snauwaert, J. Swings, I. Klare, W. Witte, T. Van Autgaerden, S. Chapelle, C. Lammens, et al. Genotypic Diversity, Antimicrobial Resistance, and Virulence Factors of Human Isolates and Probiotic Cultures Constituting Two Intraspecific Groups of Enterococcus faecium Isolates Appl. Envir. Microbiol., July 15, 2008; 74(14): 4247 - 4255. [Abstract] [Full Text] [PDF] |
||||
|
|
S. S.Y. Wong, P.-L. Ho, and K.-Y. Yuen EVOLUTION OF ANTIBIOTIC RESISTANCE MECHANISMS AND THEIR RELEVANCE TO DIALYSIS-RELATED INFECTIONS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S272 - S280. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Huang, R. Datta, and R. Platt Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med, October 9, 2006; 166(18): 1945 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zirakzadeh and R. Patel Vancomycin-Resistant Enterococci: Colonization, Infection, Detection, and Treatment Mayo Clin. Proc., April 1, 2006; 81(4): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kachroo, T. Dao, F. Zabaneh, M. Reiter, M. T LaRocco, L. O Gentry, and K. W Garey Tolerance of Vancomycin for Surgical Prophylaxis in Patients Undergoing Cardiac Surgery and Incidence of Vancomycin-Resistant Enterococcus Colonization Ann. Pharmacother., March 1, 2006; 40(3): 381 - 385. [Abstract] [Full Text] [PDF] |
||||




